BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30098380)

  • 1. Substantial Reduction in Driveline Infection Rates With the Modification of Driveline Dressing Protocol.
    Lander MM; Kunz N; Dunn E; Althouse AD; Lockard K; Shullo MA; Kormos RL; Teuteberg JJ
    J Card Fail; 2018 Nov; 24(11):746-752. PubMed ID: 30098380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous-flow left ventricular assist devices and usefulness of a standardized strategy to reduce drive-line infections.
    Cagliostro B; Levin AP; Fried J; Stewart S; Parkis G; Mody KP; Garan AR; Topkara V; Takayama H; Naka Y; Jorde UP; Uriel N
    J Heart Lung Transplant; 2016 Jan; 35(1):108-114. PubMed ID: 26476767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients.
    Wus L; Manning M; Entwistle JW
    Heart Lung; 2015; 44(3):225-9. PubMed ID: 25746483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices.
    Mutsuga M; Okumura T; Morimoto R; Kondo T; Ito H; Terazawa S; Tokuda Y; Narita Y; Nishida K; Murohara T; Usui A
    Artif Organs; 2023 Feb; 47(2):387-395. PubMed ID: 36269680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Driveline Infection in Patients With Left Ventricular Assist Devices Implanted as Destination Therapy.
    Wasilewski G; Wiśniowska-Śmiałek S; Górkiewicz-Kot I; Milaniak I; Kaleta M; Hymczak H; Wasilewska A; Wierzbicki K
    Transplant Proc; 2024 May; 56(4):860-863. PubMed ID: 38734518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of left ventricular assist device driveline infection: A systematic literature review.
    Pavlovic NV; Randell T; Madeira T; Hsu S; Zinoviev R; Abshire M
    Heart Lung; 2019; 48(2):90-104. PubMed ID: 30573195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular assist device driveline infections in three contemporary devices.
    Schlöglhofer T; Michalovics P; Riebandt J; Angleitner P; Stoiber M; Laufer G; Schima H; Wiedemann D; Zimpfer D; Moscato F
    Artif Organs; 2021 May; 45(5):464-472. PubMed ID: 33052592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic negative pressure wound therapy is not effective for preventing driveline infection following left ventricular assist device implantation.
    Tsuji M; Kakuda N; Bujo C; Saito A; Ishida J; Amiya E; Hatano M; Shimada A; Imai H; Kimura M; Ando M; Kinoshita O; Yamauchi H; Komuro I; Ono M
    Artif Organs; 2023 Mar; 47(3):566-573. PubMed ID: 36300650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review.
    Koken ZO; Yalcin YC; van Netten D; de Bakker CC; van der Graaf M; Kervan U; Verkaik NJ; Caliskan K
    Eur J Cardiothorac Surg; 2021 Sep; 60(3):506-515. PubMed ID: 33963835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Driveline infections in left ventricular assist devices-Incidence, epidemiology, and staging proposal.
    Dettbarn E; Prenga M; Stein J; Müller M; Hoermandinger C; Schoenrath F; Falk V; Potapov E; Mulzer J; Knierim J
    Artif Organs; 2024 Jan; 48(1):83-90. PubMed ID: 37723833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driveline infections in left ventricular assist devices: implications for destination therapy.
    Sharma V; Deo SV; Stulak JM; Durham LA; Daly RC; Park SJ; Baddour LM; Mehra K; Joyce LD
    Ann Thorac Surg; 2012 Nov; 94(5):1381-6. PubMed ID: 22818961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy.
    Lumish HS; Cagliostro B; Braghieri L; Bohn B; Mondellini GM; Antler K; Feldman V; Kleet A; Murphy J; Tiburcio M; Fidlow K; Jennings D; Sayer GT; Takeda K; Naka Y; Demmer RT; Aaron JG; Uriel N; Colombo PC; Yuzefpolskaya M
    ASAIO J; 2022 Dec; 68(12):1450-1458. PubMed ID: 35239537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity Is Associated with Driveline Infection of Left Ventricular Assist Devices.
    Akay MH; Nathan SS; Radovancevic R; Poglajen G; Jezovnik MK; Candelaria IN; Averill BL; Patel MK; Kar B; Gregoric ID
    ASAIO J; 2019; 65(7):678-682. PubMed ID: 30398982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driveline Infection Risk with Utilization of a Temporary External Anchoring Suture After Implantation of a Left Ventricular Assist Device.
    Fudim M; Brown CL; Davis ME; Djunaidi M; Danter MR; Harrell FE; Stulak JM; Haglund NA; Maltais S
    ASAIO J; 2016; 62(3):291-6. PubMed ID: 26809083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and early treatment of driveline infections in ventricular assist device patients - The DESTINE staging proposal and the first standard of care protocol.
    Bernhardt AM; Schlöglhofer T; Lauenroth V; Mueller F; Mueller M; Schoede A; Klopsch C;
    J Crit Care; 2020 Apr; 56():106-112. PubMed ID: 31896443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Polymyxin-Trimethoprim Prophylaxis May Decrease the Incidence of Driveline Infections in Patients With Continuous-Flow Left Ventricular Assist Devices.
    Durand ML; Ennis SC; Baker JN; Camuso JM; McEachern KM; Kotton CN; Lewis GD; Garcia JP; MacGillivray TE
    Artif Organs; 2017 Feb; 41(2):169-175. PubMed ID: 27098102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Driveline infection according to driveline positioning in left ventricular assist device implant recipients.
    Lauenroth V; Zittermann A; Lucke S; Gummert JF; Morshuis M
    Int J Artif Organs; 2024 Feb; 47(2):118-121. PubMed ID: 38182556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Feasibility of Induction Immunosuppression When Driveline Infection Is an Indication for Cardiac Transplantation.
    Bhatia N; Voelkel AJ; Hussain Z; Sharma UC; Slaughter MS; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):675-83. PubMed ID: 26366889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.
    Pitton M; Valente LG; Oberhaensli S; Casanova C; Sendi P; Schnegg B; Jakob SM; Cameron DR; Que YA; Fürholz M
    J Heart Lung Transplant; 2023 Oct; 42(10):1445-1454. PubMed ID: 37245557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.